文献速递浆细胞疾病

年龄相关间充质基质细胞衰老与意义未明的单克隆丙种球蛋白病向多发性骨髓瘤进展相关

Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma.
PubMed 文献 · Leukemia · 2025-04-22

研究探讨衰老的骨髓间充质基质细胞(MSC)在意义未明的单克隆丙种球蛋白病(MGUS)向多发性骨髓瘤(MM)进展中的作用。发现MM和MGUS患者的骨髓MSC呈现衰老表型,衰老MSC通过上调Gremlin1解除对MM细胞增殖的抑制,且MSC衰老增加与MGUS进展风险显著升高相关。

要点

  • MM和MGUS患者的骨髓MSC与老年非癌症对照相似,呈现衰老表型。
  • 衰老MSC通过上调Gremlin1促进MM细胞增殖,解除对MM细胞增殖的抑制。
  • MSC衰老增加与MGUS患者进展为MM的风险显著升高相关。

核心结论

  • 年龄相关的衰老MSC积累可能是MGUS向MM进展的驱动因素。

研究设计与样本

  • 研究比较了MM、MGUS患者与健康年轻个体及老年非癌症对照的骨髓MSC,并进行体外共培养实验。
  • 通过照射或复制性耗竭诱导健康MSC衰老,观察其对MM细胞系增殖的影响。
  • 分析MGUS患者MSC衰老与进展为MM风险的关系。

主要发现

  • MM和MGUS患者的骨髓MSC与老年非癌症对照相似,表现出细胞增大扁平、β-半乳糖苷酶活性增加、CDKN2A表达升高和增殖速率降低的衰老表型,而健康年轻个体的MSC无此表现。
  • 与BM MSC共培养可抑制MM细胞系的增殖能力,而通过照射或复制性耗竭诱导健康MSC衰老后,这种抑制作用被解除,与非衰老MSC相比。
  • 衰老MSC中BMP拮抗剂Gremlin1表达上调,可能部分解释其对MM细胞增殖的促进作用。
  • MSC衰老增加的MGUS患者进展为MM的风险显著升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The risk of progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) increases with advancing age, suggesting that progression may be influenced by age-related changes within the bone marrow (BM) microenvironment. We hypothesise that senescent mesenchymal stromal cells (MSCs), which accumulate in the BM with age, may contribute to MGUS progression to MM. Here, we show that, like BM MSCs from aged non-cancer controls, BM MSCs from both MM and MGUS patients exhibit a senescent phenotype characterised by enlarged, flattened morphology, increased β-galactosidase activity and CDKN2A expression, and decreased proliferation rate compared with BM MSCs from healthy young individuals. While coculture with BM MSCs suppresses the proliferative capacity of MM cell lines in vitro, induction of senescence via irradiation or replicative exhaustion in healthy MSCs relieves this suppression, compared with non-senescent MSCs. This may, in part, be attributable to upregulated expression of the BMP antagonist Gremlin1 in senescent MSCs, which facillitates MM cell proliferation. Notably, the risk of progression to MM was significantly elevated in MGUS patients with increased MSC senescence. Collectively, our data provide evidence that age-related accumulation of senescent MSCs may be a driver of MGUS to MM progression.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Plakhova N, Panagopoulos V, Cantley MD, et al. Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma. Leukemia. 2025. PMID: 40263435. doi:10.1038/s41375-025-02621-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。